• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Lercanidipine Teva
    / Teva


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 10 mg

    not in the basket chart 40073 12488

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    Hypertension, mild to moderate essential hypertension.


    Contra-Indications

    Hypersensitivity to lercanidipine, to any dihydropyridine or to any of the ingredient of the preparation. Pregnancy and lactation. Women of child-bearing potential unless effective contraception is used. Left ventricular outflow tract obstruction. Untreated congestive cardiac failure. Unstable angina pectoris. Within 1 month of a myocardial infarction. Severe renal or hepatic impairment. Co-administration with cyclosporine, strong inhibitors of CYP3A4, grapefruit juice.


    Special Precautions

    Please contact distributing company for full details.


    Side Effects

    Please contact distributing company for full details.


    Drug interactions

    Please contact distributing company for full details.

    CLOSE